StockData
Accustem Sciences Inc. logo

Accustem Sciences Inc. (ACUT) stock

ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.15+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.37MP/E –Yield –

Accustem Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Accustem Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$1.20M. For fiscal 2025 it was -$850.39K.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$850.39K–
FY2024Dec 31, 2024-$664.07K–
FY2023Dec 31, 2023-$1.62M–
FY2022Dec 31, 2022-$1.81M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$248.85K-1253.8%
Q1 FY2026Mar 31, 2026-$374.18K–
Q4 FY2025Dec 31, 2025$22.36K+5300.2%
Q3 FY2025Sep 30, 2025-$604.13K–
Q2 FY2025Jun 30, 2025$21.57K–
Q1 FY2025Mar 31, 2025-$290.18K–
Q4 FY2024Dec 31, 2024$414–
Q3 FY2024Sep 30, 2024-$217.95K–
Q2 FY2024Jun 30, 2024-$209.18K–
Q1 FY2024Mar 31, 2024-$237.35K–
Q4 FY2023Dec 31, 2023-$295.03K–
Q3 FY2023Sep 30, 2023-$351.61K–
Q2 FY2023Jun 30, 2023-$522.91K–
Q1 FY2023Mar 31, 2023-$446.09K-219.9%
Q4 FY2022Dec 31, 2022-$622.26K–
Q3 FY2022Sep 30, 2022-$555.29K–
Q2 FY2022Jun 30, 2022-$1.00M–
Q1 FY2022Mar 31, 2022$371.98K–

More Accustem Sciences figures

See a number that looks wrong?